Literature DB >> 33561007

Integrated analysis of microRNA and mRNA expression profiling identifies BAIAP3 as a novel target of dysregulated hsa-miR-1972 in age-related white matter lesions.

Wen-Qing Huang1,2, Qing Lin3,4,5,6, Shuai Chen7,8, Lixiang Sun2, Qingjie Chen9, Kehui Yi3,10, Zhi Li2, Qilin Ma3,4,5,6, Chi-Meng Tzeng2,11.   

Abstract

White matter lesions known as leukoaraiosis (LA) are cerebral white matter hyperintensities observed in elderly individuals. Currently, no reliable molecular biomarkers are available for monitoring their progression over time. To identify biomarkers for the onset and progression of LA, we analyzed whole blood-based, microRNA expression profiles of leukoaraiosis, validated those exhibiting significant microRNA changes in clinical subjects by means of quantitative real-time polymerase chain reactions and determined the function of miRNA in cell lines by means of microRNA mimic transfection assays. A total of seven microRNAs were found to be significantly down-regulated in leukoaraiosis. Among the microRNAs, hsa-miR-1972 was downregulated during the early onset phase of leukoaraiosis, as confirmed in independent patients, and it was found to target leukoaraiosis-dependent BAIAP3, decreasing its expression in 293T cell lines. Functional enrichment analysis revealed that significantly dysregulated miRNAs-mRNAs changes associated with the onset of leukoaraiosis were involved in neurogenesis, neuronal development, and differentiation. Taken together, the study identified a set of candidate microRNA biomarkers that may usefully monitor the onset and progression of leukoaraiosis. Given the enrichment of leukoaraiosis-associated microRNAs and mRNAs in neuron part and membrane system, BAIAP3 could potentially represent a novel target of hsa-miR-1972 in leukoaraiosis through which microRNAs are involved in the pathogenesis of white matter lesions.

Entities:  

Keywords:  BAIAP3; biomarkers; leukoaraiosis (LA); microRNA (miRNA); white matter lesions (WMLs)

Year:  2021        PMID: 33561007      PMCID: PMC7906144          DOI: 10.18632/aging.202562

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  87 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

Review 2.  Genetic associations of leukoaraiosis indicate pathophysiological mechanisms in white matter lesions etiology.

Authors:  Qing Lin; Wen-Qing Huang; Chi-Meng Tzeng
Journal:  Rev Neurosci       Date:  2015       Impact factor: 4.353

Review 3.  Regulation of microRNA function in somatic stem cell proliferation and differentiation.

Authors:  Archana Shenoy; Robert H Blelloch
Journal:  Nat Rev Mol Cell Biol       Date:  2014-08-13       Impact factor: 94.444

4.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

Authors:  W T Longstreth; T A Manolio; A Arnold; G L Burke; N Bryan; C A Jungreis; P L Enright; D O'Leary; L Fried
Journal:  Stroke       Date:  1996-08       Impact factor: 7.914

5.  MicroRNA-mediated control of oligodendrocyte differentiation.

Authors:  Xianghui Zhao; Xuelian He; Xiaolei Han; Yang Yu; Feng Ye; Ying Chen; ThaoNguyen Hoang; Xiaomei Xu; Qing-Sheng Mi; Mei Xin; Fan Wang; Bruce Appel; Q Richard Lu
Journal:  Neuron       Date:  2010-03-11       Impact factor: 17.173

6.  MicroRNA gene expression deregulation in human breast cancer.

Authors:  Marilena V Iorio; Manuela Ferracin; Chang-Gong Liu; Angelo Veronese; Riccardo Spizzo; Silvia Sabbioni; Eros Magri; Massimo Pedriali; Muller Fabbri; Manuela Campiglio; Sylvie Ménard; Juan P Palazzo; Anne Rosenberg; Piero Musiani; Stefano Volinia; Italo Nenci; George A Calin; Patrizia Querzoli; Massimo Negrini; Carlo M Croce
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

7.  Cerebral white matter lesions and the risk of dementia.

Authors:  Niels D Prins; Ewoud J van Dijk; Tom den Heijer; Sarah E Vermeer; Peter J Koudstaal; Matthijs Oudkerk; Albert Hofman; Monique M B Breteler
Journal:  Arch Neurol       Date:  2004-10

8.  Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis.

Authors:  Z Szolnoki; F Somogyvári; A Kondacs; M Szabó; L Fodor; J Bene; B Melegh
Journal:  Acta Neurol Scand       Date:  2004-03       Impact factor: 3.209

9.  The severity of leukoaraiosis correlates with the clinical phenotype of Parkinson's disease.

Authors:  Seung-Jae Lee; Joong-Seok Kim; Kwang-Soo Lee; Jae-Young An; Woojun Kim; Yeong-In Kim; Bum-Soo Kim; So-Lyung Jung
Journal:  Arch Gerontol Geriatr       Date:  2008-10-31       Impact factor: 3.250

10.  Blood-brain barrier permeability and long-term clinical and imaging outcomes in cerebral small vessel disease.

Authors:  Joanna M Wardlaw; Fergus N Doubal; Maria Valdes-Hernandez; Xin Wang; Francesca M Chappell; Kirsten Shuler; Paul A Armitage; Trevor C Carpenter; Martin S Dennis
Journal:  Stroke       Date:  2012-12-11       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.